Prestige Biologics scraps planned reverse stock split after shareholder vote fails

Bitget2026/09/30 09:25

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Prestige Biologics withdrew its planned reverse stock split following rejection at its 12th annual shareholders’ meeting on Sept. 30, 2026.
The correction cancels the Sept. 11, 2026 disclosure on the consolidation plan, including related changes to the par value per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930901128), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Prestige Biologics scraps planned reverse stock split after shareholder vote fails

You may also like

Crypto prices